Hemorrhagic Fever with Renal Syndrome
📧 Sign up to get email alerts when something new happens for Hemorrhagic Fever with Renal Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Hantavirus Registry - HantaReg
The HantaReg hantavirus registry, sponsored by the University of Cologne, is currently recruiting participants. The registry aims to collect…
-
CLINICAL_TRIALS withdrawal · 2025-06-27Clinical Trial Update: Ribavirin for Hemorrhagic Fever With Renal Syndrome [Phase 2]
Phase 2 trial of ribavirin for hemorrhagic fever with renal syndrome has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Combination HTNV and PUUV DNA Vaccine [Phase 1]
A Phase 1 trial updating completion and results posting for a combination Hantaan virus and Puumala virus DNA vaccine.
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Efficacy of Intravenous Immunoglobulin in Patients With Hemorrhagic Fever With Renal Syndrome: a Prospective Study [Phase 4]
Phase 4 trial updating the efficacy of intravenous immunoglobulin in patients with hemorrhagic fever with renal syndrome.
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Safety and Immunogenicity of a Hantaan Virus DNA Vaccine and a Puumala Virus DNA Vaccine, For The Prevention of Hemorrhagic Fever With Renal Syndrome [Phase 2]
Phase 2 trial update assessing safety and immunogenicity of Hantaan and Puumala virus DNA vaccines for prevention of hemorrhagic fever with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-12-01Clinical Trial Update: Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever [Phase 2]
Phase 2a immunogenicity study of a Hantaan/Puumala virus DNA vaccine for prevention of Hemorrhagic Fever with Renal Syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS [Phase 3]
A Phase 3 trial evaluating long-term immunity of the Hantavax vaccine in people at high risk for hemorrhagic fever with renal syndrome has c…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines [Phase 1]
Phase 1 trial evaluating the safety, tolerability, and immunogenicity of Hantaan and Puumala virus DNA vaccines for hemorrhagic fever with r…